<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//FR">
<HTML>
<HEAD>
 <LINK HRef="../CSS/ggrcm.css"   Rel="stylesheet" Type="text/css">
 <META name="description" content="M&eacute;dicaments &agrave; base de imiquimod">
 <META name="keywords" content="Centre Belge d'Information Pharmacoth&eacute;rapeutique; imiquimod">
 <TITLE>M&eacute;dicaments &agrave; base de Immunoglobulines</TITLE>
</HEAD>

<BODY bgcolor="#FFFFFF" LeftMargin="0" RightMargin="0" TopMargin="0" BottomMargin="0" MarginWidth="0" MarginHeight="0">
  <A Name="TopOfPage"></A>

  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%"><A HRef="../HeaderTxt/LeCBIP.htm">Le C.B.I.P.</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/NousContacter.htm">Nous contacter</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/Liens.htm">Sites Int&eacute;ressantes</A></TD>
   </TR> 
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%" Class="footer">Bon &agrave; savoir</TD>
    <TD Width="30%"><A HRef="../Index.htm"><B>Le R&eacute;pertoire</B></A></TD>
    <TD Width="30%" Class="footer">Folia</TD>
   </TR> 
   <TR> 
    <TD ColSpan="4"><HR></TD>
   </TR> 
  </TABLE> 


  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
   <TR>
    <TD>
     <H1>M&eacute;dicaments &agrave; base de <FONT Color="red">Immunoglobulines</FONT></H1>
     <TABLE Width="100%" Border="0" CellPadding="5" CellSpacing="10">
      <TR>
       <TD vAlign="top" Width="33%">
         <P><FONT CLASS="Text">12. Immunit&eacute;<BR>12.2. Immunoglobulines<BR>12.2.1. Immunoglobulines polyvalentes<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_LBA.htm">12.2.1.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_LBA.htm#MP_01769">-Multigam</A> [<FONT class="footer">immunoglobulines (plasma humain)</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_LBA.htm#MP_01771">-Sandoglobuline</A> [<FONT class="footer">immunoglobulines (plasma humain)</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_LBA.htm#MP_04099">-Nanogam</A> [<FONT class="footer">immunoglobulines (plasma humain)</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_LBA.htm#MP_05096">-Gammanorm</A> [<FONT class="footer">immunoglobulines (plasma humain)</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_LBA.htm#MP_05128">-Privigen</A> [<FONT class="footer">immunoglobulines (plasma humain)</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_LBA.htm#MP_05252">-Octagam</A> [<FONT class="footer">immunoglobulines (plasma humain)</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_LBA.htm#MP_05337">-Hizentra</A> [<FONT class="footer">immunoglobulines (plasma humain)</FONT>]<BR>
       </TD>
       <TD vAlign="top" Width="33%">
         <A Class="MP_INMP" HREF="../MPG/MPG_LBA.htm#MP_06018">-Gamunex</A> [<FONT class="footer">immunoglobulines (plasma humain)</FONT>]<BR>
         <P><FONT CLASS="Text">12. Immunit&eacute;<BR>12.2. Immunoglobulines<BR>12.2.2. Immunoglobulines sp&eacute;cifiques contre l'h&eacute;patite B<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_LBB.htm">12.2.2.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_LBB.htm#MP_01772">-Hepacaf</A> [<FONT class="footer">immunoglobulines antih&eacute;patite B (plasma humain)</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_LBB.htm#MP_05837">-Zutectra</A> [<FONT class="footer">immunoglobulines antih&eacute;patite B (plasma humain)</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_LBB.htm#MP_05853">-NeoHepatect</A> [<FONT class="footer">immunoglobulines antih&eacute;patite B (plasma humain)</FONT>]<BR>
         <P><FONT CLASS="Text">12. Immunit&eacute;<BR>12.2. Immunoglobulines<BR>12.2.4. Immunoglobulines anti-D<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_LBD.htm">12.2.4.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_LBD.htm#MP_01776">-Rhogam</A> [<FONT class="footer">immunoglobulines anti-Rh(D) (plasma humain)</FONT>]<BR>
         <P><FONT CLASS="Text">12. Immunit&eacute;<BR>12.2. Immunoglobulines<BR>12.2.6. Immunoglobulines sp&eacute;cifiques anticytom&eacute;galovirus<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_LBF.htm">12.2.6.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_LBF.htm#MP_01777">-Ivegam-CMV</A> [<FONT class="footer">immunoglobulines anticytom&eacute;galovirus (plasma humain)</FONT>]<BR>
         <P><FONT CLASS="Text">12. Immunit&eacute;<BR>12.3. Immunomodulateurs<BR>12.3.1. Immunosuppresseurs en cas de transplantation<BR>12.3.1.1. Immunoglobulines antilymphocytes<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_LCAA.htm">12.3.1.1.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_LCAA.htm#MP_01794">-ATG-Fresenius</A> [<FONT class="footer">immunoglobulines antilymphocytes T (s&eacute;rum de lapin)</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_LCAA.htm#MP_01805">-Thymoglobuline</A> [<FONT class="footer">immunoglobulines antilymphocytes T (s&eacute;rum de lapin)</FONT>]<BR>
       </TD>
      </TR>
     </TABLE>
<P Class="datum">
 <A Href="#TopOfPage">
 <IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A>&nbsp;
</P>

    </TD>
   </TR>
  </TABLE>
 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
  <TR>
   <TD Align="center">
    <HR WIDTH="90%" SIZE="1" COLOR="#008000" NOSHADE>
    <SPAN Class="footer">
 Centre Belge d 'Information Pharmacoth&eacute;rapeutique (C.B.I.P. asbl) <BR>
 c/o Heymans Instituut, De Pintelaan 185, 9000 Gent<BR>
 </SPAN>
 <A HRef="" Target="_top" Class="footer_link"><font color="#0000FF"></font></A> -
 <A HRef="mailto:redaction@cbip.be" Class="footer_link"><font color="#0000FF">redaction@cbip.be</font></A>
 - <A HRef="../Headertxt/Avertissement.htm" target="_blank" class="footer_link"><FONT Color="#0000FF">Avertissement / Disclaimer</FONT></A>
   </TD>
  </TR>
 </TABLE>

<script language="JavaScript" type="text/javascript" SRC="../JS/wz_tooltip.js"></script>
</BODY>
</HTML>
